Industries > Life Sciences & Healthcare > Data Analytics Solutions for Healthcare Industry

Data Analytics Solutions for Healthcare Industry

Our clients benefit from healthcare data analytics because it simplifies the process of sifting through massive amounts of information about the research, development, and marketing of pharmaceuticals and medical equipment.

Blogs | The Power of Data Visualization in the UK's Healthcare Sector

SGAs Methodology for Analyzing Health Care Data

By harnessing our cutting-edge technologies, we achieve a remarkable 70% to 90% reduction in processing and analysis times for healthcare data. We seamlessly integrate trial data with patient records, medical histories, and adverse event data, yielding more precise trial insights. This scalability not only slashes operating expenses but also boosts return on investment.

Our expert team utilizes platform-specific APIs, crawlers, and an array of tools to gather data efficiently. To weed out false or non-useful warnings, our dedicated data engineers and specialists apply stringent company standards and inclusion/exclusion logic to parsed data. We implement universal... Read More

Healthcare Data Analytics Solutions

How Can SGA’s Healthcare Data Analytics Services Boost Your Productivity?

Our services accelerate healthcare data processing and analysis to reduce the average processing time by up to 70–90%. We combine trial details, patient details, medical history, and adverse event data for better trial insights. This scalability benefits the organization by reducing operations cost and boosting ROI. Our team extracts data from various sources using different techniques customized for each platform and file format, like APIs and custom crawlers. Our team of data engineers and experts apply business rules and inclusion/exclusion logic to the parsed data to rule out most false/non-useful alerts. All the data gathered in SGA undergoes basic standardization to ensure zero duplicate alerts. Stringent quality dashboards are created to measure and monitor the day-to-day performance of data extractors. SGA remains the preferred partner of life sciences & healthcare companies across the U.S. and Europe.

What We Offer

For a medication trial to be successful, researchers need access to high-quality data promptly so they may make informed decisions that will improve patient outcomes. In terms of platform management, SGA is unparalleled. 

As the 'go-to solution' supplier, we are the experts in the fields of patent data, drug and med-tech protection, tracking related patents, and having access to significant patent registers and regulatory organizations. 

We provide you and your team with a specialized, white-labeled, machine learning (ML)-enabled market study solution with exclusive first access to data. 


Industry Leaders

SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.

12+ Languages

Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships)

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.

Who We Work With


SG Analytics - Healthcare - Whitepaper - Emergence of Novel Immune-Mediated Therapies


Emergence of Novel Immune - Mediated Therapies

Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...

Technological  Advancements


Future Trends and Technological Advances in Vaccine and Disease Prevention

The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...

SGA Whitepaper Market Entry in 2023


Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...

Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high quality, white labelled research coverage.